PTH(1–84) Is Associated With Improved Quality of Life in Hypoparathyroidism Through 5 Years of Therapy

CONTEXT: In hypoparathyroidism, quality of life (QOL) is compromised as compared to normal subjects. We previously reported our results showing an association with recombinant human PTH(1–84) therapy in hypoparathyroidism and improvement in QOL measures for 1 year. OBJECTIVE: We tested the hypothesi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cusano, Natalie E., Rubin, Mishaela R., McMahon, Donald J., Irani, Dinaz, Anderson, Laura, Levy, Elizabeth, Bilezikian, John P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Endocrine Society 2014
Témata:
Endocrine Care
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4184077/
https://ncbi.nlm.nih.gov/pubmed/24978675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2267
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky